RWJ-67657

Item number	Size	Delivery time	Price
TGM-T16812-2mg	2 mg	7 - 10 business days*	40.00€
TGM-T16812-5mg	5 mg	7 - 10 business days*	63.00€
TGM-T16812-1mL	1 ml	7 - 10 business days*	71.00€
TGM-T16812-10mg	10 mg	7 - 10 business days*	97.00€
TGM-T16812-25mg	25 mg	7 - 10 business days*	228.00€
TGM-T16812-50mg	50 mg	7 - 10 business days*	366.00€
TGM-T16812-100mg	100 mg	7 - 10 business days*	592.00€
TGM-T16812-500mg	500 mg	7 - 10 business days*	1,249.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: RWJ-67657 (JNJ 3026582) is an orally active, selective p38alpha and p38beta MAPK... more

Close menu

Product information "RWJ-67657"

Description: RWJ-67657 (JNJ 3026582) is an orally active, selective p38alpha and p38beta MAPK inhibitor (IC50s: 1 and 11 µM, respectively), with no activity at p38gamma and p38delta, and demonstrates cardioprotective effects. Target: p38 MAPK. Smiles: OCCC#Cc1nc(c(-c2ccncc2)n1CCCc1ccccc1)-c1ccc(F)cc1. References: Shahin R, et al. Research advances in kinase enzymes and inhibitors for cardiovascular disease treatment. Future Sci OA. 2017 Aug 8,3(4):FSO204.

Keywords:	JNJ 3026582
Supplier:	TargetMol
Supplier-Nr:	T16812

Properties

Application:	p38 alpha inhibitor, p38 beta inhibitor
MW:	425.5 D
Formula:	C27H24FN3O

Database Information

CAS :	215303-72-3\| Matching products
KEGG ID :	K04441 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "RWJ-67657"

Write a review